Skip to main content
. 2017 Feb 7;12(2):e0170750. doi: 10.1371/journal.pone.0170750

Table 5. The overall median survivals in patients with advanced HCC treated with TACE according to BCLC C HCC Prognostic (BCHP) score.

BCHP score Value (%) Median Survival (months) (95% CI@) P value from log rank test
1 36 (15.2) 30.8 (19.4, 42.3) 0.0001
2 57 (23.9) 28.4 (13.7, 43.2)
3 73 (30.7) 17.8 (11, 24.6)
4 39 (16.4) 9.8 (6.9, 12.7)
5 23 (9.7) 7.6 (5.8, 9.4)
6 8 (3.4) 2.6 (1, 4.2)
7 2 (0.8) 2.2
Overall 238 (100) 16.2 (11.7, 20.7)